Stemexpress, LLC

Folsom, CA Doing business as CGT Global

UEI
V6D4CLG1QU37
CAGE
5VLJ3
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Self Certified Small Disadvantaged Business
  • For Profit Organization
  • Woman Owned Small Business
  • Woman Owned Business
  • Limited Liability Company
Entity structure
Corporate Entity (Not Tax Exempt)
NAICS codes registered in SAM.gov
SAM.gov registration date
Physical address
1743 Creekside Dr #200, Folsom, CA 95630, USA
Website
cgt.global
Industry
  1. Health Care
  2. Health Care Equipment & Services
  3. Health Care Providers & Services
  4. Health Care Services
SIC code
80 Health Services

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Recent federal awards

Stemexpress, LLC's 5 most recent federal contract and grant awards, newest first. Amounts are dollars obligated.
Award Agency Obligated Awarded
Human donor blood for bioassay development Contract · 75F40124P00405 Food and Drug Administration $47,440
Cder-2023-118707 delivery of human blood donor for bioassay development, under solicitation FDA-RFQ-cder-2023-118707. Contract · 75F40123P00230 Food and Drug Administration $51,218
Items needed in product development to qualify new processes for IND submission. Contract · 75N90023P00339 NIH Clinical Center $17,235
Items needed in product development to qualify new processes for IND submission. Contract · 75N90023P00222 NIH Clinical Center $17,510
Lab supplies - mobilized leukopak g-CSF Contract · 75N91023P00114 National Cancer Institute $16,635

About Stemexpress, LLC

Stemexpress, LLC, doing business as CGT Global, is a small disadvantaged woman-owned business located in Folsom, California, specializing in providing human biological samples and specimen collection services for research and development in the life sciences. Registered in SAM.gov since July 30, 2012, the company has established itself as a key supplier of human donor biological materials to federal research agencies, with a focus on supporting advanced medical and scientific research initiatives.

The company has secured multiple federal contract awards primarily from health-related agencies, including the Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), and specific institutes like the National Cancer Institute and National Human Genome Research Institute. Their contract awards, ranging from $12,010 to $396,400, have involved supplying specialized biological samples such as human donor blood, COVID-19 positive serum samples, breast tumor specimens, and mobilized leukopak cells for various research purposes. These contracts typically involve providing biological materials for bioassay development, product development, genomic research, and scientific testing. Most of their awards have been purchase orders without specific set-aside designations, though one FDA contract was designated as a total small business set-aside. The contracts demonstrate Stemexpress's capability to support critical research efforts, including pandemic-related studies and advanced medical research requiring specialized human biological samples.

SBA capabilities narrative

Established in 2010, California-based StemExpress, LLC is a leading biospecimen provider supporting research, clinical trials, and drug development. Women-owned and operated with over 10 years of industry experience, StemExpress develops custom products and procedures to Academic, Biotechnological, Diagnostic, Pharmaceutical, and Contract Research Organizations (CRO's), ensuring all unique needs are met. To view more on our Federal Contracting please visit Fedlinks.

Quick answers

What is Stemexpress, LLC's UEI?

Stemexpress, LLC's Unique Entity ID (UEI) in SAM.gov is V6D4CLG1QU37.

What is Stemexpress, LLC's CAGE code?

Stemexpress, LLC's CAGE code is 5VLJ3.

What is Stemexpress, LLC's primary NAICS code?

Stemexpress, LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).

Where is Stemexpress, LLC located?

Stemexpress, LLC's physical address in SAM.gov is 1743 Creekside Dr #200, Folsom, CA 95630, USA.

Is Stemexpress, LLC registered in SAM.gov?

Yes. Stemexpress, LLC's SAM.gov registration is active through June 10, 2027.

What is Stemexpress, LLC's most recent federal award?

Stemexpress, LLC's most recent federal contract award is Human donor blood for bioassay development (75F40124P00405), from Food and Drug Administration, on September 6, 2024.

On GovTribe

See Stemexpress, LLC's full federal record

  • Federal contract awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors